Equity benchmark indices drifted lower during early hours on Wednesday amid weak global cues with pharma stocks losing the most. At 10:15 am, the BSE SandP Sensex was down by 181 points or 0.47 per cent at 38,226 while the Nifty 50 lost by 54 points or 0.48 per cent at 11,269. Sectoral indices at the National Stock Exchange were mixed with Nifty pharma slipping by 1.8 per cent, private bank by 0.7 per cent and IT by 0.6 per cent. But Nifty PSU bank gained by 3.5 per cent. Among stocks, Cipla fell by 1.9 per cent to Rs 762.65 per share while Sun Pharma was down by 2 per cent and Dr Reddy's by 1.3 per cent. The others which lost were Hindalco, Bajaj Finance, Kotak Mahindra Bank, Wipro and GAIL.
From the supply of antiviral drug remdesivir stabilising in India after shortage as per producer Cipla, to Russia becoming the first nation to declare a vaccine ready for use - here are the top news updates on the Covid-19 pandemic. The health of India's former President Pranab Mukherjee has worsened and his condition is critical, as per doctors. He had recently tested positive for Sars-CoV-2 coronavirus infection and also undergone an emergency surgery for a brain clot on August 10. Meanwhile, noted Urdu poet Rahat Indori passed away. He was suffering from Covid and experienced two heart attacks before succumbing. The Railways ministry has announced that regular passenger train services across the country will continue to remain suspended until further orders. However, 230 special trains will continue to ply between select destinations. India's Covid tally has crossed the 22.68 lakh-mark with the country noting 50,000+ new cases every day. India's death toll is past 45,200 while over 15.83 lakh patients have been discharged, suggesting a healthy recovery rate. In international news, schools have begun to reopen in countries like the United States of America and the United Kingdom. This, even as a report suggested that around 97,000 children in US contracted Covid in the last 2 weeks of July. New Zealand broke its streak of 102 days without a locally transmitted case by finding a new infection. Prime Minister Jacinda Ardern put Auckland under lockdown. The country now has 22 active cases, with the total Covid tally at a little over 1,200. Watch the full video for more.
Credit: HT Digital Content Duration: 03:13Published
Equity benchmark indices shaved off early gains but ended in the positive terrain on Monday with pharma stocks leading the rally. At the closing bell, the BSE SandP Sensex was up by 142 points or 0.37 per cent at 38,182 while the Nifty 50 gained by 61 points or 0.54 per cent at 11,275. All sectoral indices at the National Stock Exchange were in the green with Nifty pharma up by 5.4 per cent, realty by 2.8 per cent and auto by 0.8 per cent. Among stocks, Cipla was the flavour of the day by gaining 9.48 per cent to Rs 797.70 per share while Sun Pharma ticked up by 3.4 per cent to Rs 544.10 and Dr Reddy's by 2.6 per cent to Rs 4,691.65.
Equity benchmark indices advanced by 0.8 per cent during early hours on Monday with pharma, auto and financial stocks in the lead. At 10:15 am, the BSE SandP Sensex was up by 300 points or 0.79 per cent at 38,341 while the Nifty 50 gained by 92 points or 0.82 per cent at 11,306. Except for Nifty metal which slipped marginally, all sectoral indices at the National Stock Exchange were in the green with Nifty pharma gaining by 3.3 per cent, financial service by 1.3 per cent and auto by 0.8 per cent. Among stocks, Cipla was up by 5.3 per cent to Rs 767.50 per share while Sun Pharma ticked up by 1.6 per cent to Rs 534.20. Mahindra and Mahindra gained by 4.3 per cent, Tata Motors by 1.8 per cent, Larsen and Toubro by 3.6 per cent, State Bank of India by 2.2 per cent and Kotak Mahindra Bank by 2 per cent. However, Maruti Suzuki slipped by 1.1 per cent, Hindalco by 0.8 per cent and Nestle India by 0.3 per cent.
Ambassador of Israel to India Ron Malka on July 31 visited special testing site created at Dr Ram Manohar Lohia (RML) Hospital today to witness ongoing trials since last three days of rapid COVID-19 testing. Malka was accompanied by Principal Scientific Adviser to GOI, K. VijayRaghavan. This joint research is progressing according to the plan. It's being jointly developed in cooperation with DRDD Ministry of Defence Israel and DRDO, CSIR and PSA, India.
Director General of CSIR, Shekhar C Mande said that there is emergent evidence that COVID-19 is air-borne which can risk many people at once even if one person is infected. He said, "Few days ago, about 200-odd scientists wrote to WHO to reconsider it and says it's air-borne. The difference is that when you sneeze or cough, it releases aerosols in air. WHO thought it spreads through touching the infected surface. There is emergent evidence in the world that when we speak or sing even then we release particles, even they are smaller in size and because they are not large, they keep floating in the air. And, when it suspended in the air even in a crowded place one person is infected, there is potential risk that these individuals can risk others because there are suspended particles in the air."
Health and Family Welfare Minister Dr Harsh Vardhan launched Drug Discovery Hackathon on July 02. Human Resource Development Minister Ramesh Pokhriyal Nishank also joined the launch ceremony. Hackathon was launched via video conferencing. CSIR DG, Dr. Shekhar C Mande said, "CSIR is extremely pleased to participate in this Drug Discovery Hackathon."